Pfizer mulling sale of consumer healthcare business

Oct 10 (Reuters) - Pfizer Inc said on Tuesday it was reviewing strategic alternatives for its consumer healthcare business, including a full or partial separation of the unit.

The company said any decision related to the strategic alternatives would be made during 2018. (Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)